Treatment of Refractory RS3PE Syndrome With Tocilizumab

J Clin Rheumatol. 2021 Dec 1;27(8S):S814. doi: 10.1097/RHU.0000000000001451.

Authors

Hiroshi Sato¹, Soichi Yamada, Sei Muraoka, Shotaro Masuoka, Mai Kawazoe, Toshihiro Nanki

Affiliation

¹ From the Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.

PMID: 35073642
DOI: 10.1097/RHU.0000000000001451

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized*
Edema
Humans
Syndrome
Synovitis*

Substances

Antibodies, Monoclonal, Humanized
tocilizumab